| |
| |
|
| Insider
Information: |
Shafer Bradford J |
| Relationship: |
EVP, Gen. Counsel, Sec... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
720,844 |
|
|
Indirect Shares
|
8,250 |
|
|
| Direct
Value |
$9,745,773 |
|
|
|
Indirect Value
|
$132,908 |
|
|
| Total
Shares |
729,094 |
|
|
| Total
Value |
$9,878,680 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
247,568 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-08-20 |
4 |
D |
$14.00 |
$21,602 |
D/D |
(1,543) |
247,577 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-08-01 |
4 |
S |
$25.73 |
$419,431 |
D/D |
(16,200) |
248,235 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-05-20 |
4 |
D |
$20.55 |
$82,364 |
D/D |
(4,008) |
248,860 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-05-20 |
4 |
D |
$13.02 |
$20,103 |
D/D |
(1,544) |
249,120 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-02-20 |
4 |
D |
$10.22 |
$11,886 |
D/D |
(1,163) |
250,664 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
251,165 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
251,827 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
251,916 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
256,723 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-11-20 |
4 |
D |
$22.52 |
$54,116 |
D/D |
(2,403) |
257,674 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2010-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
260,077 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-05-20 |
4 |
D |
$26.67 |
$128,203 |
D/D |
(4,807) |
261,527 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-08-01 |
4 |
S |
$26.00 |
$191,672 |
D/D |
(7,300) |
264,435 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$761,512 |
D/D |
(29,402) |
264,932 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2006-05-03 |
4 |
OE |
$3.10 |
$189,989 |
D/D |
40,761 |
271,735 |
|
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-08-20 |
4 |
D |
$14.05 |
$60,513 |
D/D |
(4,307) |
277,831 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-05-20 |
4 |
D |
$17.80 |
$76,718 |
D/D |
(4,310) |
282,138 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$598,819 |
D/D |
(31,869) |
285,047 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
294,334 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-02-20 |
4 |
D |
$39.98 |
$172,314 |
D/D |
(4,310) |
295,764 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-11-20 |
4 |
D |
$36.40 |
$166,312 |
D/D |
(4,569) |
300,074 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-06-07 |
4 |
S |
$35.04 |
$1,087,572 |
D/D |
(31,038) |
303,416 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-08-20 |
4 |
D |
$35.89 |
$135,413 |
D/D |
(3,773) |
304,643 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
308,416 |
0 |
- |
|
103 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
